Cos-effectiveness and Cost-benefit Analysis of Children Received Typel Inactivated Vaccine against Hemorrhagic Fever with Renal Syndrome

Objective:Cos-effectiveness and cost-benefit analysis of children received type I nactivated vaccine againsthemrrhagic fever with renal syndrome.Materials and Methods:Based on trial field materials of type I inactivated vaccine against HFRS in Jiande county cos-effectiveness and cost benefit were computed in 5~9 and 10~14 age groups.Results CER and BCR of the two age groups were under 1and above 0 respectively;CET and HFRS case fare of vaccine protecting of 5~9 age group-was almost 2~3 times than that of 10~14 age group.Conclusion 10~14 age group children should be inoculated with inactivated vaccine against HFRS in high mobidity area.